The CEGX Blog

Latest News from Cambridge Epigenetix


Epigenetics Experts Interview - Dr Brock Christensen

Dr Christensen received his B.S. from the University of Wisconsin Madison in Medical Microbiology & Immunology in 2002, and his Ph.D. from


Epigenetics Experts Interview - Professor Sir Shankar Balasubramanian


Professor Sir Shankar Balasubramanian, Co-founder of Cambridge Epigenetix and pioneering researcher, shares his perspectives on Chairing


Epigenetics Experts Interview - Dr Esteban Ballestar

Dr Esteban Ballestar leads the Chromatin and Disease Group at Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona, and is a member


Epigenetics Experts Interview - Dr Miguel Branco

Dr Miguel Branco undertook his PhD at the MRC Clinical Sciences Centre in London with Professor Ana Pombo, where he studied the spatial


Epigenetics Experts Interview - Professor Wolf Reik

Professor Wolf Reik is a leader in molecular biology research, having played a key role in advancing global understanding of epigenetic

Epigenetics Experts Interview - Dr Phil Ewels

Dr Phil Ewels is Deputy Head of Facility and Bioinformatician at the National Genomics Infrastructure (NGI), part of SciLifeLab — the Swedish


Epigenetics Experts Interview - Dr Michael Booth

Dr Michael Booth is a Postdoctoral Researcher in Professor Hagan Bayley’s lab and a Junior Research Fellow at Merton College, Oxford. During


Epigenetics Experts Interview - Professor Anjana Rao


Professor Anjana Rao’s research in the field of epigenetics has shaped global understanding and current opinion regarding the role of DNA

Researchers led by CEGX founder Prof. Sir Shankar Balasubramanian show importance of 5hmC in human glioblastoma

Raiber et al. Base resolution maps reveal the importance of 5-hydroxymethylcytosine in a human glioblastoma. npj Genome Medicine. Article number: 6


New oxBS paper highlights role of TET2 and DNMT1 in protecting against abnormal DNA methylation in cancer cells

Zhang et al. Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress Molecular Cell. 2017; 65;2

1 2 3 4